MetaCap

Orthofix Medical (OFIX) vs Profound Medical (PROF)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Profound Medical (PROF) has outperformed Orthofix Medical (OFIX) over the past year, gaining 6.2% versus a loss of 60.2%. Over five years, PROF leads with a -43.6% price change compared with -80.6% for OFIX. Orthofix Medical is the larger company by market cap ($247.4 million vs $233.7 million), about 1.1 times the size, while Profound Medical is growing revenue faster (+50.7% vs +2.9%).

Orthofix Medical converts more of its revenue into profit, with a net margin of -11.2% versus -264.4%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

OFIX-60.22%PROF+6.16%
+49%-8%-65%
Nov 21, 20251 yearNov 20, 2026
OFIX-80.46%PROF-47.62%
+27%-29%-86%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

OFIX versus PROF key metrics
MetricOFIXPROF
Share price$6.07$6.38
Market cap$247.41M$233.68M
1-day change-4.26%-3.19%
YTD return-59.96%-18.93%
1-year return-60.22%+6.16%
5-year return-80.64%-43.64%
Forward P/E33.72—
EPS (TTM)$-1.10$-0.94
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$822.31M$16.10M
Revenue growth (YoY)+2.85%+50.73%
Net income (latest FY)$-92.19M$-42.57M
Gross margin68.83%70.77%
Operating margin-9.90%-256.27%
Net margin-11.21%-264.44%
52-week high$16.42$8.95
52-week low$6.04$4.80
Distance from 52-week high-63.03%-28.72%
Analyst consensusbuystrong_buy
Avg. price target upside+64.74%+74.61%
Average volume481.16K208.29K
Shares outstanding40.76M36.63M
Employees1,605162
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • PROF has outperformed OFIX by 66.4 percentage points over the past year.
  • Orthofix Medical is more profitable, keeping -11.2 cents of every revenue dollar as net income versus -264.4 cents for Profound Medical.
  • Profound Medical grew revenue faster in its latest fiscal year (+50.73% vs +2.85%).

About Orthofix Medical

OFIX stock →

Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction.

Health Care · Medical/Dental Instruments · 1,605 employees

About Profound Medical

PROF stock →

Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue.

Health Care · Medical/Dental Instruments · 162 employees

OFIX vs PROF FAQ

Which is bigger, Orthofix Medical or Profound Medical?

Orthofix Medical (OFIX) is larger, with a market capitalization of $247.41M compared with $233.68M for Profound Medical (PROF).

Which stock has performed better over the past year, OFIX or PROF?

PROF returned +6.16% over the past 12 months, compared with -60.22% for OFIX (price return, excluding dividends). Past performance does not predict future results.

Are Orthofix Medical and Profound Medical in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons